T1	Treatment 0 12	Cyclosporine
T2	Treatment 317 408	randomized, controlled trial testing the benefit of the Pgp modulator, cyclosporin A (CsA).
T3	Treatment 446 544	assigned to treatment with cytarabine and infusional daunorubicin with or without intravenous CsA.
